z-logo
open-access-imgOpen Access
Efficacy and safety of recombinant human parathyroid hormone (1–34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis
Author(s) -
Jing Deng,
Zhengping Feng,
Yue Li,
Tingting Pan,
Qifu Li,
Changhong Zhao
Publication year - 2018
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000013341
Subject(s) - medicine , endocrinology , bone mineral , femoral neck , osteoporosis , parathyroid hormone , n terminal telopeptide , alkaline phosphatase , urology , calcium , osteocalcin , biochemistry , chemistry , enzyme

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here